Immediate Management: Treat for Severe Vitamin B12 Deficiency (Pseudo-TMA)
This patient has pseudo-thrombotic microangiopathy (pseudo-TMA) secondary to severe vitamin B12 deficiency, NOT true TTP or aHUS, and should be treated immediately with high-dose parenteral vitamin B12 supplementation—NOT plasma exchange. 1, 2, 3
Critical Diagnostic Reasoning
The constellation of findings points definitively away from true TMA:
- Markedly low vitamin B12 is the key diagnostic clue
- Normal Coombs tests exclude autoimmune hemolysis
- Schistocytes with pancytopenia in B12 deficiency occur due to intramedullary hemolysis creating fragile RBCs that shear easily, NOT from platelet microthrombi 4
- Elevated LDH (800) reflects both hemolysis AND ineffective erythropoiesis from B12 deficiency 3, 5
The Reticulocyte Count is Your Differentiator
Check the absolute reticulocyte count immediately. This single test distinguishes pseudo-TMA from true TMA:
- Low/inappropriately normal reticulocyte count = pseudo-TMA from B12 deficiency (erythropoiesis is suppressed) 4, 2
- Elevated reticulocyte count = true hemolytic process like TTP/aHUS (bone marrow responding appropriately)
Reticulocytopenia is a universal finding in pseudo-TMA and is absent in true TMA 4. This is because B12 is essential for DNA synthesis and erythropoiesis—without it, the bone marrow cannot mount a reticulocyte response despite hemolysis.
Immediate Treatment Protocol
Start Parenteral Vitamin B12 Now
- Intramuscular cyanocobalamin 1000 mcg daily for 1-2 weeks 6, 7
- Then transition to weekly injections for 4 weeks 6
- Then monthly maintenance indefinitely 6, 8
DO NOT Start Plasma Exchange
Approximately 38.8% of pseudo-TMA cases are misdiagnosed as TTP and inappropriately treated with plasma exchange 4. This is:
- Unnecessary
- Costly
- Potentially harmful
- Ineffective for B12 deficiency 2
The only reason some patients with pseudo-TMA appear to "respond" to plasma exchange is because fresh frozen plasma contains vitamin B12, providing inadvertent supplementation 1.
Monitoring Expected Response
You should see rapid improvement:
- Hemoglobin rise within 7-10 days 7
- Complete resolution of pancytopenia within 2 weeks 7, 6
- Schistocytes disappear as RBC production normalizes
- LDH normalizes as hemolysis resolves 5
When to Consider ADAMTS-13 Testing
While the clinical picture strongly suggests pseudo-TMA, if the reticulocyte count is elevated or there is diagnostic uncertainty, send ADAMTS-13 activity urgently 9, 10:
- ADAMTS-13 <10% = TTP (requires plasma exchange) 9
- ADAMTS-13 normal = confirms pseudo-TMA (continue B12 only)
However, given the markedly low B12 and clinical context, this is likely unnecessary unless the patient fails to respond to B12 within 48-72 hours.
Critical Pitfall to Avoid
The absence of macrocytosis does NOT exclude B12 deficiency. Concomitant conditions can mask macrocytosis 1:
- Iron deficiency
- Thalassemia trait (as in the case report 1)
- Chronic disease
In this patient, the MCV may be normal despite severe B12 deficiency. Always check B12 levels in any patient with unexplained pancytopenia and hemolysis, regardless of MCV 5, 8.
Investigate the Underlying Cause
Once stabilized, determine why B12 is deficient:
- Check anti-intrinsic factor antibodies and anti-parietal cell antibodies for pernicious anemia 6, 8
- Dietary history (strict vegetarian/vegan diet) 7
- Gastrointestinal pathology (malabsorption, gastric surgery)
- Consider bone marrow aspiration if diagnosis remains uncertain—will show megaloblastic erythropoiesis 7
Supportive Care
- Transfuse packed RBCs for symptomatic anemia (Hb 2 is life-threatening) 5
- Monitor for refeeding syndrome when starting B12 (hypokalemia risk)
- Avoid platelet transfusion unless active bleeding—counts will recover with B12
Neurologic Evaluation
Severe B12 deficiency can cause irreversible neurologic damage:
- Perform thorough neurologic examination looking for posterior column signs (loss of vibration/proprioception), peripheral neuropathy, cognitive changes 8
- If neurologic symptoms present, continue daily B12 injections longer (up to 2 weeks) before transitioning to weekly dosing